Key result
A 5-gene vascular endothelial model demonstrates strong diagnostic performance for HCM with an AUC >0.8.
Why the study?
Previous studies combined integrated scRNA-seq with bulk RNA data to screen biomarkers for cardiomyopathy, but specific biomarkers for hypertrophic cardiomyopathy remained to be identified using this approach.
Does integrated bioinformatics analysis identify vascular endothelial cell-related biomarkers for hypertrophic cardiomyopathy?
Does integrated bioinformatics analysis identify vascular endothelial cell-related biomarkers for hypertrophic cardiomyopathy?
This study uses integrated bioinformatics analysis of scRNA-seq and bulk RNA data to identify vascular endothelial cell-related biomarkers for hypertrophic cardiomyopathy.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for endothelial biomarkers in hypertrophic cardiomyopathy; requires prospective validation before clinical use.
Background: Previous studies combined integrated scRNA-seq with bulk RNA data to screen biomarkers for cardiomyopathy. This study extended this approach to identify biomarkers specific for hypertrophic cardiomyopathy (HCM). ... | Find, read and cite all the research you need on Tech Science Press
No takes yet. Share an insight, caveat, or question.
Wang et al. (2024) studied Hypertrophic cardiomyopathy (n=316). Vascular endothelial cell-related biomarkers (DYRK1B, GADD45A, IVNS1ABP, LMOD2, PHLDB2) vs. Control samples was evaluated on Diagnostic efficacy of the 5-gene model (AUC > 0.8). A diagnostic model based on five vascular endothelial cell-related hub genes (DYRK1B, GADD45A, IVNS1ABP, LMOD2, and PHLDB2) demonstrated strong diagnostic performance for hypertrophic cardiomyopathy with AUC values > 0.8.
Synapse has enriched 10 related papers. Consider them for comparative context: